US gum manufacturer Adams is seen as a 'must-have' acquisition for
Cadbury Schweppes if it wants to truly become a global player. But
it faces strong opposition from rival players.
UK confectionery and drinks group Cadbury Schweppes is preparing a
$2 billion (€2.27bn) bid for the chewing gum and cough drops arm of
Pfizer, the world's largest drugs company, a British Sunday
newspaper reported.